Asia’s patent offices carry the volume while Western megacaps in software, chips and medtech do most of the heavy filing. Drug majors are riding older IP waves instead of driving the boom. According to fresh WIPO data, innovators filed a record 3.7 million patent applications in 2024, up 4.9% from 2023 and the fastest growth…
In 2024, the US and Europe led in pharma value creation while GLP-1s disrupted the landscape
GLP-1 juggernauts Eli Lilly and Novo Nordisk, whose combined $1.18 trillion market cap now exceeds Johnson & Johnson, AbbVie, and Merck combined, have staked their claim as stock market darlings. This momentum is particularly evident in Novo Nordisk’s remarkable trajectory, reaching a $604 billion market capitalization by March 2024 and securing its position as the…